Truncating variants in ATM were also associated with a higher risk for ER-positive disease (OR=3.42; 95% CI 2.33 to 5.21) than ER-negative disease (OR=1.59; 95% CI 0.80 to 3.00), though not significantly so (Pdiff=0.11). This evidence concerns the gene ATM and glycogen storage disease VI.